BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC

Position in PRME — Prime Medicine, Inc.

CIK 1352860 BLUE BELL, PA

Position in PRME

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$95,312

+$1,300 QoQ

Shares Held

25,830

-4.4% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#109

of 187 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC holds $146,305 across 4 Biotechnology names. PRME ranks #1 (65.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRME	Prime Medicine, Inc. This page	25,830	$95,312
2	NTLA	Intellia Therapeutics, Inc.	1,757	$29,728
3	INCY	Incyte Corp	139	$15,757
4	CRSP	CRISPR Therapeutics AG	101	$5,508

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$95,312	25,830	-4.4%	Shares	Sole	2026-08-06
2026-03-31	$94,012	27,015	—	Shares	Sole	2026-05-11
No filing history on record for this holder in this stock.